Zhejiang Haisen Pharmaceutical Co., Ltd. (SHE:001367)
China flag China · Delayed Price · Currency is CNY
19.32
+0.60 (3.21%)
At close: Oct 28, 2026

SHE:001367 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Net Income
148.83135.88122.56104.67107.5994
Depreciation & Amortization
2323.1816.7913.4114.313.03
Other Amortization
1.030.850.491.991.681.71
Loss (Gain) From Sale of Assets
---0.24--
Asset Writedown & Restructuring Costs
0.40.41.230.961.210.67
Loss (Gain) From Sale of Investments
-6.71-6.71-3-0.323.85-1.45
Provision & Write-off of Bad Debts
2.732.730.090.431.09-0.27
Other Operating Activities
23.491.120.61.6-7.454.29
Change in Accounts Receivable
-16.48-16.48-27.23-20.5611.11-22.35
Change in Inventory
-3.05-3.0537.64-19.1-38.88-20.63
Change in Accounts Payable
17.1717.1711.19-4.6-19.2936.22
Change in Other Net Operating Assets
20.7120.715.77-0.080.22-0.24
Operating Cash Flow
212.77177.45167.1680.6274.95107.04
Operating Cash Flow Growth
38.35%6.16%107.35%7.56%-29.98%39.93%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Capital Expenditures
-55.2-152.26-64.75-57.44-20.19-33.32
Sale of Property, Plant & Equipment
---0.12-0
Investment in Securities
-121.48-144.9830.32-0.99-1.21
Investing Cash Flow
-176.69-297.25-61.75-57-21.18-34.52

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Long-Term Debt Repaid
--1.72-1.86-1.04-1.15-0.88
Lease Payments
-1.72-1.72-1.86-1.04-1.15-0.88
Total Debt Repaid
-1.72-1.72-1.86-1.04-1.15-0.88
Net Debt Issued (Repaid)
-1.72-1.72-1.86-1.04-1.15-0.88
Issuance of Common Stock
-3.5825.46698.45--
Common Dividends Paid
-17.67-17.45-34--0.71-16.43
Other Financing Activities
0.03---24.08-1.9-1.4
Financing Cash Flow
-19.36-15.59-10.39673.33-3.77-18.71

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Foreign Exchange Rate Adjustments
-1.970.912.680.615.52-1.46
Net Cash Flow
14.76-134.4797.69697.5555.5252.35

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Free Cash Flow
157.5725.19102.4123.1754.7673.72
Free Cash Flow Growth
5829.33%-75.40%341.91%-57.68%-25.73%32.89%
Free Cash Flow Margin
28.35%4.73%21.72%5.83%12.95%18.95%
Free Cash Flow Per Share
1.030.170.690.170.490.66
Levered Free Cash Flow
105.43-21.283.57-18.14-2.3544.27
Unlevered Free Cash Flow
105.48-20.9883.8-18.12-2.3144.34
Free Cash Flow After Leases
155.8523.47100.5522.1353.672.84

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Cash Income Tax Paid
9.388.9319.2733.385.2412.89
Change in Working Capital
20.0120.0128.39-42.36-47.31-4.94